Absorption, Distribution, Metabolism, and Elimination (ADME) constitute the fundamental pharmacokinetic processes that govern the fate of drugs within the human body.
Absorption initiates the journey as the drug enters the bloodstream, influenced by factors like formulation and administration route.
Distribution guides the drug to target tissues, determined by blood flow, permeability, and binding characteristics.
Metabolism, predominantly in the liver, transforms the drug into metabolites, facilitating elimination and enhancing water solubility.
Elimination, occurring through renal excretion, hepatic excretion, and other routes, marks the final phase.
Bioavailability, half-life, and first-pass metabolism are pivotal parameters influencing drug efficacy, dosage frequency, and duration of action. The intricate interplay of these processes underscores the concept of pharmacokinetics, essential for comprehending drug behavior. Variability in individual factors, drug interactions, and the emergence of adverse reactions further emphasize the need for meticulous consideration of ADME in drug development and clinical application. Prodrugs and therapeutic drug monitoring underscore the innovative approaches to drug design and optimization, ensuring both efficacy and safety. Regulatory bodies demand a thorough understanding of ADME parameters during drug evaluation, emphasizing its critical role in shaping pharmaceutical landscapes.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia